Product Information

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $5.0652 per EA under NDC 65862083430. Its NADAC has been published 261 times since May 1, 2019.

FDA first approved this application on Dec 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB

Amlodipine, Valsartan and Hydrochlorothiazide
$5.0652per EA

Strength

5; 12.5; 160 mg/1; mg/1; mg/1

NDC

65862083430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206180

FDA Approved

12/19/2017

TE Code

AB

On Market Since

12/19/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has been published 261 times since May 1, 2019, and over the history we have for it it has risen 344.0%. The table below summarizes its recorded NADAC range and movement.

Current price$5.0652 per EA
All-time high$7.2976 (Jun 11, 2025)
All-time low$0.8291 (Jun 19, 2019)
52-week high$7.1689
52-week low$5.0652
Median price$1.2732
Average price$3.7804
Largest weekly change+443.7% (Apr 17, 2024)
Weeks tracked261
Tracking sinceMay 1, 2019

Price History

1W

-7.8%

1M

-7.8%

3M

-22.7%

6M

-27.8%

1Y

-29.3%

3Y

+340.1%

5Y

+340.1%

All

+344.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine, Valsartan and Hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $5.0652 per EA (NDC 65862083430), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has risen 344.0%. It has been tracked across 261 weekly CMS publications since May 1, 2019.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

Since May 1, 2019, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has ranged from a low of $0.8291 (Jun 19, 2019) to a high of $7.2976 (Jun 11, 2025), with a median of $1.2732 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB (NDC 65862083430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.